FDA Approves First Drug to Reverse Aging Genes
The FDA has authorized the first human trials for ER-100 a drug designed to reverse aging by targeting specific genes.…
Obesity Drug Market Set for 5x Growth by 2030, Reaching $77 Billion
The obesity drug market is anticipated to surge fivefold by 2030, reaching $77 billion, driven by escalating obesity ra…
Pharma R&D Investment: Oncology Leads Despite Heart Disease
Pharmaceutical research and development (R&D) investments are heavily concentrated in oncology, with nearly 10,000 drug…
PA-915: The Potential First Anti-Anxiety Vaccine
PA-915 is an experimental drug targeting the PAC1 receptor in the brain, showing promise in treating anxiety, stress, a…
IU1 Drug: Extending Human Life by 250 Years?
IU1, a drug developed by scientists at Osaka University, targets protein imbalance in cells, a key factor in aging and…
First Human Trials for Tooth Regrowth Drug
For the first time, a drug designed to stimulate tooth regrowth in humans has entered clinical trials. The drug targets…